Masimo Corporation MASI recently announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription.

It was hard to miss CoCo Vandeweghe’s commercial for the Masimo MightySat during Indian Wells. The 30-second ad for the newly released fingertip pulse oximeter played on nearly every changeover.

Masimo Corp. and Apple Inc. have filed dueling post-trial briefs in a California federal court, following a retrial over ...

Masimo sells a range of devices used for patient monitoring that feature a proprietary pulse oximetry technology called Signal Extraction Technology (SET). In the latest update on that patent spat ...

Masimo (NASDAQ:MASI – Get Free Report) had its price objective raised by equities research analysts at Raymond James from ...

Offers optional dual IBP, and EtCo 2 — Now with Masimo SET ® Pulse Oximetry! The fully-functional Waveline Touch features a 12.1" color TFT display with a touch-screen interface. It features ...

The FDA has published a set of long-awaited recommendations to the industry to help ensure that pulse oximeters work correctly across all skin tones. | The FDA has published a set of long-awaited ...

ECG leads were placed on the infant's chest. Masimo and Nellcor oximeter sensors were randomly allocated to each foot. Measurements were collected for 10mins. Screens from the oximeters and ECG ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. Pacific time. A live webcast ...

Masimo traded as high as $178.84 and last traded at $178.84, with a volume of 28200 shares traded. The stock had previously closed at $174.65. Several other research firms have also commented on MASI.